Results 31 to 40 of about 143,184 (363)
Background: Hepsin (HPN), a type II trans-membrane serine protease, has been reported to be one of the most up regulated genes in prostate cancer. The aim of the present study was to find out immuno-histochemistry based phenotypic expression of HPN in ...
Madhu Mati Goel+3 more
doaj +1 more source
Testosterone undecanoate is a hormone agent with long-acting potential and is used for testosterone replacement therapy for hypogonadism. This study was designed to investigate application of testosterone undecanoate in maintaining high androgen levels ...
Jinho An, Hyunseok Kong
doaj +1 more source
Benign prostatic hyperplasia (BPH) is the most common benign disease of the prostate gland and is caused by benign hyperplasia of the smooth muscle cells and stromal cells in this important gland.
Zhaojun Yu+7 more
semanticscholar +1 more source
Polyuria in patients with lower urinary tract symptoms: Prevalence and etiology
Abstract Introduction Patients with lower urinary tract symptoms (LUTS) can be subcategorized into polyuria, normal or oliguria groups. Polyuria may be caused by pathologies including diabetes mellitus (DM), chronic kidney disease (CKD), diabetes insipidus (DI), or primary polydipsia (PPD).
George Z. Fisch+8 more
wiley +1 more source
Are β3‐adrenoceptor gene polymorphisms relevant for urology?
Abstract Aims β3‐adrenoceptors (ARs) are an important drug target for the treatment of overactive bladder syndrome (OAB) and are under investigation for other indications. The human β3‐AR gene is polymorphic; an exchange of amino acid tryptophan (Trp) for arginine (Arg) in position 64 of the receptor protein is the most frequent and best‐studied ...
Martin C. Michel
wiley +1 more source
Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle. [PDF]
The transcription factors Elk1 and serum response factor (SRF) are central regulators of cell cycle and phenotype in various cell types. Elk1 is activated by phosphorylation (serine-383), while activation of SRF requires its co-factor, myocardin ...
Andersson, Karl-Erik+10 more
core +5 more sources
Benign prostatic hyperplasia : Part 1- diagnosis [PDF]
Peer reviewedPublisher ...
N'Dow, James Michael Olu, Wilt, Timothy
core +2 more sources
Abstract Objective To examine trends in incidence of acute urinary retention, subsequent benign prostatic hyperplasia‐related treatment and mortality in the era of medical therapy for benign prostatic hyperplasia. Additionally, to compare mortality with the general population.
Maria Bisgaard Bengtsen+4 more
wiley +1 more source
This work investigated the spectrum-effect relationships between high performance liquid chromatography (HPLC) fingerprints and the anti-benign prostatic hyperplasia activities of aqueous extracts from Saxifraga stolonifera.
Xing-Dong Wu+8 more
doaj +1 more source
A novel family of beta mixture models for the differential analysis of DNA methylation data: an application to prostate cancer [PDF]
Identifying differentially methylated cytosine-guanine dinucleotide (CpG) sites between benign and tumour samples can assist in understanding disease. However, differential analysis of bounded DNA methylation data often requires data transformation, reducing biological interpretability.
arxiv +1 more source